Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HTC-867 Administered Orally to Healthy Japanese Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 31 Dec 2010
At a glance
- Drugs HTC 867 (Primary)
- Indications Cognition disorders
- Focus Adverse reactions
- 31 Dec 2010 New trial record